1D | 0.0 % |
1W | 1.0 % |
2W | 5.9 % |
1M | 5.2 % |
3M | 0.8 % |
6M | 0.5 % |
9M | -6.2 % |
1Y | 3.5 % |
Alpha
-3.3%
|
Beta
0.32
|
sharpe-R
0.23
|
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
|
sharpe-R Benchmark
1.69
|
Calculation Frequency | Daily |
Latest Valuation Time | 2025-02-04 07:50:17 |
Launch Date | 2023-01-01 00:00:00 |
First Valuation Date | 2021-01-01 00:00:00 |
Max. DrawDown | -13.4% |
Max. DrawDown Benchmark | -8.41% |
This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 5.
The assets selection in this portfolio is based on: Macro-Pattern Mix St..Try Our Peformance Checker Tool
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
NTRA Natera, Inc. | Buy | 19.89% | 0.37% | 2025-01-31 |
Asset | Action | Perf % |
---|---|---|
GKOS | Sell All | 0.03% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
GKOS Glaukos Corporation | Buy | 18.79% | 0.87% | 2025-01-20 |
NTRA Natera, Inc. | Buy | 19.8% | 0% | 2025-01-31 |
Asset | Action | Perf % |
---|---|---|
DNLI | Sell All | 8.81% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
DNLI Denali Therapeutics Inc. | Buy | 20.1% | 8.03% | 2025-01-17 |
GKOS Glaukos Corporation | Buy | 18.94% | 1.68% | 2025-01-20 |
Asset | Action | Perf % |
---|---|---|
AXSM | Sell All | 12.15% |
INSM | Sell All | 11.11% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | Buy | 19.35% | -1.94% | 2025-01-16 |
INSM Insmed Incorporated | Buy | 20.38% | 3.29% | 2025-01-16 |
DNLI Denali Therapeutics Inc. | Buy | 19.95% | 1.2% | 2025-01-17 |
GKOS Glaukos Corporation | Buy | 19.75% | 0% | 2025-01-20 |
Asset | Action | Perf % |
---|---|---|
TNDM | Sell All | NA |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
TNDM Tandem Diabetes Care, Inc. | Buy | 18.56% | -5.9% | 2025-01-07 |
AXSM Axsome Therapeutics, Inc. | Buy | 19.35% | -1.94% | 2025-01-16 |
INSM Insmed Incorporated | Buy | 20.38% | 3.29% | 2025-01-16 |
DNLI Denali Therapeutics Inc. | Buy | 19.95% | 1.2% | 2025-01-17 |
GKOS Glaukos Corporation | Buy | 19.75% | 0% | 2025-01-20 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
TNDM Tandem Diabetes Care, Inc. | Buy | 19.54% | 0.47% | 2025-01-07 |
AXSM Axsome Therapeutics, Inc. | Buy | 19.44% | -0.06% | 2025-01-16 |
INSM Insmed Incorporated | Buy | 20.16% | 3.63% | 2025-01-16 |
DNLI Denali Therapeutics Inc. | Buy | 19.43% | 0% | 2025-01-17 |